AVE 0.00% 0.3¢ avecho biotechnology limited

marketing is the key to poh growth, page-30

  1. 5,765 Posts.
    lightbulb Created with Sketch. 309
    It is just possible that POH will not have to do more than a phase 2 trial for OXYPatch. They raised a very specific sum of money recently. Whats to say a major pharma hasnt already said OK we'll give you what you want, but you have to show that phase 2 is sexy and we'll do the rest.

    Esra in ths SKY interview in Jan said that the BIG pharma deals are out there.

    Lets join the dots gang.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
56 96190952 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 59101557 17
View Market Depth
Last trade - 16.12pm 07/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.